Dr. Geller’s work in maternal health focuses on factors associated with maternal morbidity and mortality. She was the Principal Investigator of a CDC/ASPH cooperative agreement “Investigation of factors associated with maternal mortality.” Dr. Geller has developed an innovative model for early identification of high-risk pregnant women and has done extensive work in Illinois to reduce maternal morbidity and mortality. As a member of two maternal deaths review committees in Illinois and she is leading the statewide effort to examine severe maternal morbidity.
Dr. Geller is currently a Co-PI on a 5 year $10 million HRSA State Maternal Health Innovation Program entitled “Innovations to ImPROve Maternal OuTcomEs in Illinois (I PROMOTE-IL)”. I PROMOTE-IL is a multi-faceted initiative aimed at improving maternal health and reducing maternal mortality and severe maternal morbidity during pregnancy and through one year postpartum
Dr. Geller’s work extends to global women’s health as well. She has conducted several studies related to the safety and efficacy of misoprostol in SouthEast Asia and Africa. Her international research in maternal morbidity and mortality began with a 5-year NICHD-funded randomized clinical trial comparing the use of oral misoprostol to placebo for the reduction postpartum hemorrhage in women delivering at home or in rudimentary health facilities in rural India. This has led to work with several other international agencies including the Gates and MacArthur Foundations, non-profit organizations and foreign governments to promote implementation of misoprostol into community-based settings in the developing world.
Additionally, in collaboration with the Victoria University, Wellington and the New Zealand Ministry of Health, Dr. Geller has engaged in several initiatives to improve maternal and newborn health in Maori women. Working with Maori health providers, community leaders and government Dr. Geller has collaborated in implementing the first national review to assess potential preventability of severe maternal morbidities in the country. She is currently conducting two funded clinical trials to address disparities in cervical cancer screening.
Geller S, Garland C, Horne A. Statewide Severe Maternal Morbidity Review in Illinois. Obstetrics and Gyecology. (in press) 2020.
Lawton B, Filoche S, MacDonald EJ, Stanley J, Meeks M, Stone P, Storey F, Geller S. Examining adverse fetal/neonatal outcomes associated with severe maternal morbidity. Aust N Z J Obstet Gynaecol. Epub ahead of print April 21, 2020.
Lepine S, Geller S, Pledger M, Lawton B, MacDonald EJ. Severe maternal morbidity due to obstetric haemorrhage: Potential preventability. Aust N Z J Obstet Gynaecol. 2020 Apr;60(2):212-217.
Maki PM, Wu M, Rubin LH, Fornelli D, Drogos LL, Geller S, Schulman LP, Banuvar S, Little DM, Conant RJ. Hot Flashes are Associated with Altered Brain Function during a Memory Task. Menopause. 2020 Mar;27(3):269-277.
Adcock A, Storey F, Lawton B, Bennett M, Lamber C, Edmonds L, Stevenson K, Geller S, Cram F. He Korowai Manaaki: Mapping Assets to Inform a Strengths-Based Indigenous-Led Wrap-Around Maternity Pathway. Aust J Prim Health. 2019 Nov;25(5):509-514.
Zimmermann K, Carnahan LR, Khare MM, Chakraborty A, Risser H, Molina Y, and Geller S. Effectiveness of a Faith-placed Cardiovascular Health Promotion Intervention for Rural Adults. J Health Dispar Res Pract. 2019;12(6):8.
MacDonald EJ, Lepine S, Pledger M, Geller S, Lawton B. Stone P. Pre-eclampsia causing severe maternal morbidity – a national retrospective review of preventability and opportunities for improved care. Aust N Z J Obstet Gynaecol. 2019;59(6):825–830.
Koch AR, Geller SE. Racial and Ethnic Disparities in Pregnancy-Related Mortality in Illinois, 2002-2015. J Womens Health. 2019 Aug;28(8):1153-1160.
For a list of Dr. Geller’s publications, please click the following link: